PL369960A1 - Sposoby leczenia zespołu suchego oka za pomocą kombinacji steroidu przeciwzapalnego i substancji pobudzającej wydzielanie muc-1 - Google Patents

Sposoby leczenia zespołu suchego oka za pomocą kombinacji steroidu przeciwzapalnego i substancji pobudzającej wydzielanie muc-1

Info

Publication number
PL369960A1
PL369960A1 PL02369960A PL36996002A PL369960A1 PL 369960 A1 PL369960 A1 PL 369960A1 PL 02369960 A PL02369960 A PL 02369960A PL 36996002 A PL36996002 A PL 36996002A PL 369960 A1 PL369960 A1 PL 369960A1
Authority
PL
Poland
Prior art keywords
secretagogue
muc
methods
combination
dry eye
Prior art date
Application number
PL02369960A
Other languages
English (en)
Inventor
Daniel A. Gamache
John M. Yanni
Duzee Barry F. Van
Original Assignee
Alcon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon, Inc. filed Critical Alcon, Inc.
Publication of PL369960A1 publication Critical patent/PL369960A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL02369960A 2001-10-11 2002-09-26 Sposoby leczenia zespołu suchego oka za pomocą kombinacji steroidu przeciwzapalnego i substancji pobudzającej wydzielanie muc-1 PL369960A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32860801P 2001-10-11 2001-10-11

Publications (1)

Publication Number Publication Date
PL369960A1 true PL369960A1 (pl) 2005-05-02

Family

ID=23281647

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02369960A PL369960A1 (pl) 2001-10-11 2002-09-26 Sposoby leczenia zespołu suchego oka za pomocą kombinacji steroidu przeciwzapalnego i substancji pobudzającej wydzielanie muc-1

Country Status (11)

Country Link
US (2) US20030109509A1 (pl)
EP (1) EP1438037A1 (pl)
JP (1) JP2005505592A (pl)
KR (1) KR20050030884A (pl)
CN (1) CN1564683A (pl)
BR (1) BR0213179A (pl)
CA (1) CA2462272A1 (pl)
MX (1) MXPA04003299A (pl)
PL (1) PL369960A1 (pl)
WO (1) WO2003030893A1 (pl)
ZA (1) ZA200402356B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2560824A1 (en) * 2004-03-25 2005-10-13 Bausch & Lomb Incorporated Use of loteprednol etabonate for the treatment of dry eye
US7189697B2 (en) * 2004-04-13 2007-03-13 Trustees Of Tufts College Compositions and uses of a galectin for treatment of dry eye syndrome
US20070014833A1 (en) * 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
US20060292099A1 (en) * 2005-05-25 2006-12-28 Michael Milburn Treatment of eye disorders with sirtuin modulators
WO2007032997A1 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation containing loteprednol etabonate for treatment of dry eye
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
US7691811B2 (en) 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
US20080161275A1 (en) * 2006-12-05 2008-07-03 Resolvyx Pharmaceuticals, Inc. Compositions and methods for the treatment of inflammatory disease
SI2220076T1 (sl) 2007-11-15 2012-05-31 Gilead Sciences Inc Inhibitorji replikacije virusa humane imunske pomankljivosti
KR20100097156A (ko) 2007-11-16 2010-09-02 베링거 인겔하임 인터내셔날 게엠베하 사람 면역결핍 바이러스 복제의 억제제
US9289494B2 (en) 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions
EP3500344A4 (en) * 2016-08-19 2020-08-05 Akrivista, LLC METHODS OF DIAGNOSIS AND TREATMENT OF DRY EYE SYNDROME AND COMPOSITIONS FOR TREATMENT OF A HUMAN EYE
BR112020003276A2 (pt) 2017-08-18 2020-09-01 Akrivista, LLC métodos de diagnóstico e tratamento da síndrome do olho seco e composições para tratamento de um olho humano

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4131651A (en) * 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) * 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4633392A (en) * 1982-04-05 1986-12-30 Texas Instruments Incorporated Self-configuring digital processor system with logical arbiter
US4868154A (en) * 1986-02-19 1989-09-19 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with melanocyte stimulating hormones
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4818537A (en) * 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US5278151A (en) * 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
ES2084722T3 (es) * 1990-05-29 1996-05-16 Boston Ocular Res Composicion para tratamiento del ojo seco.
ZA912797B (en) * 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
JPH0727504B2 (ja) * 1990-12-10 1995-03-29 インターナショナル・ビジネス・マシーンズ・コーポレイション ネットワークの構成を定義するシステム、ネットワークのための構成パラメータを生成する方法及びネットワークを構成するためのシステム
WO1992016904A1 (en) * 1991-03-18 1992-10-01 Echelon Corporation Binder interface structure
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5688765A (en) * 1992-04-21 1997-11-18 The Schepens Eye Research Institute, Inc. Ocular therapy in Sjogren's syndrome using topically applied androgensor TGF-β
ATE185697T1 (de) * 1992-04-21 1999-11-15 Schepens Eye Res Inst Androgentherapie am auge beim sjögrensyndrom
US5958912A (en) * 1992-04-21 1999-09-28 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β
US6107289A (en) * 1992-04-21 2000-08-22 The Schepens Eye Research Institute, Inc. Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β
US5805897A (en) * 1992-07-31 1998-09-08 International Business Machines Corporation System and method for remote software configuration and distribution
US5290572A (en) * 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
WO1994004155A1 (en) * 1992-08-19 1994-03-03 Health Resource Institute, Ltd. Dehydroepiandrosterone therapy for the treatment of eye disorders
US5455265A (en) * 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US5845090A (en) * 1994-02-14 1998-12-01 Platinium Technology, Inc. System for software distribution in a digital computer network
US5500802A (en) * 1994-05-31 1996-03-19 Morris; James M. System and method for creating configurators using templates
JP3611610B2 (ja) * 1994-11-18 2005-01-19 富士通株式会社 データ独立型コンピュータシステムにおける機器接続定義の自動生成方式
US5872928A (en) * 1995-02-24 1999-02-16 Cabletron Systems, Inc. Method and apparatus for defining and enforcing policies for configuration management in communications networks
US5894571A (en) * 1995-08-14 1999-04-13 Dell U.S.A., L.P. Process for configuring software in a build-to-order computer system
US5696166A (en) * 1995-10-31 1997-12-09 Yanni; John M. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
US6035105A (en) * 1996-01-02 2000-03-07 Cisco Technology, Inc. Multiple VLAN architecture system
US5900407A (en) * 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
US5724509A (en) * 1996-04-22 1998-03-03 Motorola, Inc. Method and apparatus for synchronizing implementation of configuration information in a communication system
US6061332A (en) * 1996-06-25 2000-05-09 Mci Communications Corporation System and method for the automated configuration of network elements in a telecommunications network
US5758071A (en) * 1996-07-12 1998-05-26 Electronic Data Systems Corporation Method and system for tracking the configuration of a computer coupled to a computer network
US5875306A (en) * 1996-10-01 1999-02-23 International Business Machines Corporation Reconfiguring computer resources in a distributed computer enterprise environment
US6009274A (en) * 1996-12-13 1999-12-28 3Com Corporation Method and apparatus for automatically updating software components on end systems over a network
US5841972A (en) * 1997-01-03 1998-11-24 Ncr Corporation System using displayed configuration utility on monitor including list of target nodes, for administering interconnected nodes of computer network
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6243815B1 (en) * 1997-04-25 2001-06-05 Anand K. Antur Method and apparatus for reconfiguring and managing firewalls and security devices
US5951680A (en) * 1997-06-24 1999-09-14 International Business Machines Corporation Configurator object
US6247128B1 (en) * 1997-07-22 2001-06-12 Compaq Computer Corporation Computer manufacturing with smart configuration methods
US5995757A (en) * 1997-08-29 1999-11-30 Dell Usa, L.P. Software installation and testing for a build-to order computer system
US6263387B1 (en) * 1997-10-01 2001-07-17 Micron Electronics, Inc. System for automatically configuring a server after hot add of a device
US6154835A (en) * 1997-10-01 2000-11-28 Micron Electronics, Inc. Method for automatically configuring and formatting a computer system and installing software
US6041347A (en) * 1997-10-24 2000-03-21 Unified Access Communications Computer system and computer-implemented process for simultaneous configuration and monitoring of a computer network
US6233609B1 (en) * 1997-10-31 2001-05-15 Selectica, Inc Method and apparatus for remote interaction with and configuration of a wan-based knowledge base
US6064982A (en) * 1997-11-12 2000-05-16 Netscape Communication Corporation Smart configurator
US6295556B1 (en) * 1997-11-18 2001-09-25 Microsoft Corporation Method and system for configuring computers to connect to networks using network connection objects
US6317815B1 (en) * 1997-12-30 2001-11-13 Emc Corporation Method and apparatus for formatting data in a storage device
US6202070B1 (en) * 1997-12-31 2001-03-13 Compaq Computer Corporation Computer manufacturing system architecture with enhanced software distribution functions
US6182275B1 (en) * 1998-01-26 2001-01-30 Dell Usa, L.P. Generation of a compatible order for a computer system
US6236901B1 (en) * 1998-03-31 2001-05-22 Dell Usa, L.P. Manufacturing system and method for assembly of computer systems in a build-to-order environment
US6092189A (en) * 1998-04-30 2000-07-18 Compaq Computer Corporation Channel configuration program server architecture
US6173319B1 (en) * 1998-05-08 2001-01-09 Attachmate Corporation Using a systems network architecture logical unit activation request unit as a dynamic configuration definition in a gateway
US6263382B1 (en) * 1998-07-29 2001-07-17 Compaq Computer Corporation Sizer for interactive computer system configuration
US6066182A (en) * 1998-11-05 2000-05-23 Platinum Technology Ip, Inc. Method and apparatus for operating system personalization during installation
US6347331B1 (en) * 1999-04-26 2002-02-12 International Business Machines Corporation Method and apparatus to update a windows registry from a hetrogeneous server
WO2001034546A2 (en) * 1999-11-09 2001-05-17 Alcon Universal Ltd. Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
DK1228027T3 (da) * 1999-11-09 2004-07-19 Alcon Inc 3-heteroatomsubstituerede og to carbonhomologe af 15-HETE og fremgangsmåder til anvendelse
DK1237549T3 (da) * 1999-11-09 2004-06-07 Alcon Inc Lipoxin A4 og dets analoger til behandling af törre öjne

Also Published As

Publication number Publication date
US20030109509A1 (en) 2003-06-12
WO2003030893A1 (en) 2003-04-17
EP1438037A1 (en) 2004-07-21
CA2462272A1 (en) 2003-04-17
US20060069075A1 (en) 2006-03-30
KR20050030884A (ko) 2005-03-31
CN1564683A (zh) 2005-01-12
BR0213179A (pt) 2004-09-14
ZA200402356B (en) 2005-03-29
JP2005505592A (ja) 2005-02-24
MXPA04003299A (es) 2004-07-23

Similar Documents

Publication Publication Date Title
AU2002308606A1 (en) Game machines and method of upgrading game machines
AU2001287824A1 (en) Method and device for controlling the blowing of an inflatable prosthetic envelope
GB2375782B (en) Sand control method and apparatus
PL369960A1 (pl) Sposoby leczenia zespołu suchego oka za pomocą kombinacji steroidu przeciwzapalnego i substancji pobudzającej wydzielanie muc-1
AU2002300990A1 (en) Method and device for producing molten iron
AU2002238005A1 (en) Method and apparatus for securing portions of memory
GB2365469B (en) Sand control method and apparatus
AU2001233098A1 (en) Cavity enlarger method and apparatus
GB9925289D0 (en) Method and means for adjusting the timing of user-activity-dependent changes of operational state of an apparatus
HUP0302014A3 (en) Method and device for process controlling
EP1100127A4 (en) INSULATING SILICON WAFER AND PROCESS FOR PRODUCING INSULATING SILICON WAFER
AU2001267473A1 (en) Method and apparatus for a controlled customisation of the cornea
EP1420677A4 (en) CLOSING DEVICE AND INSTALLATION METHOD THEREFOR
AU2001244814A1 (en) Apparatus and method for power integrated control
EP1321834A4 (en) ELECTRONIC WRIST WATCH AND CONTROL METHOD FOR ELECTRONIC WRIST WATCH
AU2002215483A1 (en) Method and device for the preparation of foundry sand
AUPR842501A0 (en) A method for identification and development of therapeutic agents
IL151835A0 (en) Methods of treatment and kits comprising a growth hormone secretagogue
PT2476526E (pt) Processo e dispositivo para a produção de uma placa fabricada a partir de fibras ou aparas
AU2001267972A1 (en) Apparatus and method for interpreting programming instructions
AU2001242302A1 (en) Method of treating phenylketonuria and means therefor
IL146465A0 (en) Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods
AU2002225241A1 (en) A device and method for treating the skin of a subject
GB2382241B (en) Speaker volume control means and method of operation
GB2355841B (en) Display device, portable electronic device and method of controlling display device

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)